BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
67 hedge funds and large institutions have $20.7M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-12
Holders Change %
-15.19%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
26
Closed
20
Calls
$301K
Puts
$33K
Net Calls
+$268K
Net Calls Change
+$277K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$1.09M |
| 2 |
AC
Armistice Capital
New York
|
+$1.09M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$788K |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$263K |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$263K |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$3.27M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$946K |
| 3 |
Goldman Sachs
New York
|
-$708K |
| 4 |
Jane Street
New York
|
-$411K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$340K |
